摘要
Tumor-associated myeloid cells constitute a series of plastic and heterogeneous cell populations within the tumor microenvironment(TME),and exhibit different phenotypes and functions in response to various microenvironmental signals.In light of promising preclinical data indicating that myeloid-based therapy can effectively suppress tumor growth,a series of novel immune-based therapies and approaches are currently undergoing clinical evaluation.A better understanding of the diversity and functional roles of different myeloid cell subtypes and of how they are associated with TME remodeling may help to improve cancer therapy.Herein,we focus on myeloid cells and discuss how tumor cells can simultaneously reprogram these cells through tumor-derived factors and metabolites.In addition,we discuss the interactions between myeloid cells and other cells in the TME that have the potential to directly or indirectly regulate tumor initiation,invasion,or angiogenesis.We further discuss the current and future potential applications of myeloid cells in the development of focused therapeutic strategies in cancer treatment.
基金
the National Natural Science Foundation of China(No.82073145 to Y.Y.)
Shanghai Pujiang Program(No.20PJ1412800 to Y.Y.)
Natural Science Foundation of Shanghai(No.20ZR1472900 to Y.Y.).
